| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 191,523 | 152,840 | 167,269 | 156,910 | | Cost of Revenue | 134,424 | 111,916 | 120,629 | 118,125 | | | Gross Profit | 57,099 | 40,924 | 46,640 | 38,785 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 44,880 | 39,020 | 40,056 | 43,580 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 12,219 | 1,904 | 6,584 | (4,795) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 13 | 1 | 3 | 10 | | Earnings Before Interest And Taxes | 12,232 | 1,905 | 6,587 | (4,785) | | Interest Expense | 42 | 42 | 42 | 42 | | Income Before Tax | 12,190 | 1,863 | 6,545 | (4,827) | | Income Tax Expense | 4,692 | 881 | 2,413 | (1,778) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 7,498 | 982 | 4,132 | (3,049) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,498 | 982 | 4,132 | (3,049) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $7,498 | $982 | $4,132 | ($3,049) |
|
0.02% Nasdaq 0.00%
Income Statement
